UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

The value of including thalamic atrophy as a clinical trial endpoint in multiple sclerosis

Schoonheim, MM; Ciccarelli, O; (2018) The value of including thalamic atrophy as a clinical trial endpoint in multiple sclerosis. [Editorial comment]. Neurology , 90 (15) pp. 677-678. 10.1212/WNL.0000000000005279. Green open access

[thumbnail of Ciccarelli_677.full.pdf]
Preview
 Text
Ciccarelli_677.full.pdf - Published Version
Download (128kB) | Preview
Type: Article
Title: The value of including thalamic atrophy as a clinical trial endpoint in multiple sclerosis
Open access status: An open access version is available from UCL Discovery
DOI: 10.1212/WNL.0000000000005279
Publisher version: https://doi.org/10.1212/WNL.0000000000005279
Language: English
Additional information: This version is the version of record. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Multiple sclerosis
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neuroinflammation
URI: https://discovery.ucl.ac.uk/id/eprint/10040857
Downloads since deposit
148Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item